Reme-D Raises $500,000 to Scale Affordable PCR Diagnostics
The Middle East Observer [Unofficial]
April 15, 2026
Egyptian biotech startup Reme-D has secured a $500,000 investment from the Global Innovation Fund to expand its innovative PCR testing solutions across emerging markets. Founded in 2022, the company develops room-temperature PCR kits that eliminate the need for cold-chain logistics—cutting diagnostic costs by up to 40% and improving accessibility in low-infrastructure regions. Reme-D’s services include: […]
Discussion in the ATmosphere